The FXR1 network acts as a signaling scaffold for actomyosin remodeling
Cell · 2024
DOI: 10.1016/j.cell.2024.07.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024. Verfasst von Xiuzhen Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Actomyosin, rhoA GTP-Binding Protein, RNA, Messenger, RNA-Binding Proteins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NCI.
Abstract (Originalsprache)
It is currently not known whether mRNAs fulfill structural roles in the cytoplasm. Here, we report the fragile X-related protein 1 (FXR1) network, an mRNA-protein (mRNP) network present throughout the cytoplasm, formed by FXR1-mediated packaging of exceptionally long mRNAs. These mRNAs serve as an underlying condensate scaffold and concentrate FXR1 molecules. The FXR1 network contains multiple protein binding sites and functions as a signaling scaffold for interacting proteins. We show that it is necessary for RhoA signaling-induced actomyosin reorganization to provide spatial proximity between kinases and their substrates. Point mutations in FXR1, found in its homolog FMR1, where they cause fragile X syndrome, disrupt the network. FXR1 network disruption prevents actomyosin remodeling-an essential and ubiquitous process for the regulation of cell shape, migration, and synaptic function. Our findings uncover a structural role for cytoplasmic mRNA and show how the FXR1 RNA-binding protein as part of the FXR1 network acts as an organizer of signaling reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY 10065, USA.
- National Institute of Chemistry, Hajdrihova 19, 1001 Ljubljana, Slovenia; Biosciences PhD Program, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
- National Institute of Chemistry, Hajdrihova 19, 1001 Ljubljana, Slovenia; UK Dementia Research Institute at King's College London, London SE5 9NU, UK.
- Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY 10065, USA. Electronic address: mayrc@mskcc.org.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NCI
- ERC
- Memorial Sloan Kettering Cancer Center Marie-Josée and Henry R Kravis Center for Molecular Oncology
- NIH
- Horizon 2020
- Pershing Square Sohn Cancer Research Alliance
Zitieren
APA
Chen, X., Fansler, M. M., Janjoš, U., Ule, J., & Mayr, C. (2024). The FXR1 network acts as a signaling scaffold for actomyosin remodeling. Cell. https://doi.org/10.1016/j.cell.2024.07.015
Vancouver
Chen X, Fansler MM, Janjoš U, Ule J, Mayr C. The FXR1 network acts as a signaling scaffold for actomyosin remodeling. Cell. 2024. doi:10.1016/j.cell.2024.07.015
BibTeX
@article{Chen2024,
author = {Chen, Xiuzhen and Fansler, Mervin M and Janjoš, Urška and Ule, Jernej and Mayr, Christine},
title = {The FXR1 network acts as a signaling scaffold for actomyosin remodeling},
journal = {Cell},
year = {2024},
doi = {10.1016/j.cell.2024.07.015}
}
EUVIMED